Clinical Trial Update: A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating camrelizumab in combination with famitinib and paclitaxel in advanced solid tumors; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Camrelizumab (camrelizumab)
• Famitinib (Famitinib)
• Paclitaxel (albumin-bound) (paclitaxel albumin-bound)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 2 | Status: UNKNOWN